Insight Holdings Group, LLC sold $4.6M of HNGE (indirect holdings)

Insight Holdings Group, LLC sold 65,581 indirectly-held shares of Hinge Health, Inc. (HNGE) at $70.36 ($4.61M total) across 4 trades on 2026-06-16 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Insight Holdings Group, LLC
Published Jun 19, 2026, 1:52 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 19, 2026, 2:02 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$HNGE
Neutral
medium confidence
Mentioned
$HNGE
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$HNGENeutralLow
01

Why it matters

The disclosed sale provides a fresh datapoint on insider behavior and can influence short-term sentiment, but it does not change fundamentals or guidance.

02

Market read

Traders may monitor for follow-on insider activity, but the 10b5-1 framing suggests limited incremental information about near-term performance.

03

What to watch

The article does not disclose total compensation, tax-motivated selling, or whether other insiders/funds are buying; without those, the signal is incomplete.

Relevance 5/10Novelty 5/10Timing: after-hours/filing update (Form 4 filed 2026-06-18 for 2026-06-16 trades)

Background

The filing is a SEC Form 4 insider transaction: Insight Holdings Group, LLC (10% owner) sold Hinge Health shares indirectly under a Rule 10b5-1 plan.

Company-level read

Ticker impact

$HNGENeutralMedium confidence
Context

Hinge Health disclosed an open-market sale by a 10% owner via a Rule 10b5-1 plan: 65,581 shares sold at $70.3596 on 2026-06-16.

Expected impact

Likely limited near-term price impact; any effect is more sentiment/positioning than fundamentals.

Evidence & confidence

Form 4 provides a concrete transaction size and price, yet it is explicitly under a pre-arranged 10b5-1 plan and does not indicate new operating or regulatory developments.

Market effects

No sector read-through; this is a single-company insider transaction with no stated business change.

None indicated.

None indicated.

Counterpoint

Because the sale is under a pre-arranged 10b5-1 plan and the filing shows zero shares remaining, it may reflect routine liquidity rather than bearish expectations.

Key entities

  • Hinge Health, Inc.

    Subject of the Form 4 insider transaction; 65,581 shares sold at $70.3596 by a 10% owner via 10b5-1.

  • Insight Holdings Group, LLC

    10% owner reporting an open-market sale of HNGE shares; holdings after transaction: 0 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$HNGEHighAI 8/10

Needham raises Hinge Health stock price target on client growth

Needham raised its price target for Hinge Health (NYSE:HNGE) to $135 from $115, citing strong client growth and quarterly performance. The company reported 28% year-over-year client growth, 50% revenue increase, and 154% stock return over six months. Q3 revenue was $235 million, up 52% year-over-year, with EPS of $0.66 beating estimates. Wells Fargo also raised its target to $132, noting strong margins and revenue growth.

$HNGEHighAI 8/10

Hinge Health (HNGE) Q3 2026 Earnings Call Transcript

Hinge Health (HNGE) reported Q3 2026 revenue of $235M, up 52% YoY, with gross margin at 88% and operating income at $77M. The company highlighted growth in its MSK, Migraine, and GI care programs, with strong early results in Migraine care. President Jim Pursley announced his departure at year-end to spend more time with family but will join the board.